Investigating the Impact of Treadmill-integrated Virtual Reality Training on Walking Outside the Clinic
Multiple Sclerosis
De qué trata este estudio
El registro indica que este estudio recluta participantes. La disponibilidad puede variar por centro.
- Tipo de estudio
- De intervención
- Fase
- No aplica
- Rango de edad
- 18 años - No especificado
- Sexo admitido
- Todos los sexos
- Voluntarios sanos
- No aceptados
- Participantes
- 10 Estimado
Estos son puntos de partida, no una decisión de elegibilidad. El equipo debe revisar todos los requisitos.
Las explicaciones y la navegación están en español. Los textos proporcionados por el registro, incluidos títulos, resúmenes y criterios, se conservan en su idioma original. Puedes pedir orientación en español a WCR.
Acerca de la investigación
This study will test whether a treadmill-based virtual reality walking program is safe, practical, and helpful for people with multiple sclerosis (MS). Participants will complete a 6-week training program and wear smart socks that measure how they walk before, during, and after the program. The study will also track changes in balance, fatigue, fall risk, fear of falling, confidence with walking, and overall quality of life.
Leer la descripción completa
People with multiple sclerosis (MS) often have trouble with walking and balance, which can increase the risk of falls and make daily life harder. While therapy can improve walking in a clinic, it is not always clear if those improvements carry over to real life at home or in the community. In addition, most walking tests are done over short periods and may not show how a person moves throughout the day. This study will look at new ways to better understand and improve walking in everyday settings. Researchers will use a treadmill-based virtual reality program, along with smart socks that track walking during daily activities. This approach will help show how people respond to training and whether those changes last outside the clinic. Standard care for people with MS usually includes physical therapy and clinic-based walking tests, but these may miss important changes in daily movement.
Participants will be asked to provide basic health information and complete surveys about their walking, fatigue, balance, thinking, and quality of life at different times during the study. They will also complete simple walking and balance tests to measure their mobility. As part of the study, participants will take part in a 6-week treadmill-based virtual reality training program, with two sessions each week. During the study, they will wear smart socks that collect information about how they walk in their daily lives, including before, during, and after the training program. These socks will track how often they walk, how steady they are, and how their walking changes over time. After the training ends, participants will continue wearing the socks for several weeks so researchers can see if improvements last. The results will help researchers learn if this approach can improve walking, lower fall risk, and support better mobility and quality of life for people living with MS.
¿Quién podría participar?
La lista siguiente contiene el texto del patrocinador. Puede incluir condiciones, tratamientos previos, resultados de pruebas y otros requisitos. Aparecer en tu búsqueda no significa que califiques.
Inclusion Criteria:
- Have a clinically confirmed diagnosis of multiple sclerosis (MS).
- Be 18 years of age or older.
- Demonstrate ≥10% variability in stride length, step length, or gait asymmetry.
- Can ambulate without an assistive device, with a unilateral, or with a bilateral assistive device.
- Demonstrate no more than mild cognitive impairment, indicated by the Mini-Mental State Exam (score \>19).
- Possess adequate cognitive function to understand and follow research instructions.
- Be able to safely participate in the study and training procedures as determined by study staff.
- Be fluent in English and able to communicate discomfort, fatigue, or pain in English.
- Be able to travel to Shepherd Center to complete key assessment points in-person and for in-person training sessions twice per week.
Exclusion Criteria:
- Have a diagnosis of any other neurological condition or recent orthopedic conditions that affects gait, balance, or mobility.
- Exhibit \<10% variability in stride length, step length, or gait asymmetry.
- Are unable to ambulate (i.e. wheelchair bound or bedbound individuals).
- Have legal blindness or severe visual impairment that would interfere with virtual reality engagement or safe ambulation.
- Have a body weight exceeding 300 lbs., which exceeds the safety limits of the treadmill and body weight support system.
- Have uncontrolled or untreated hypertension, hypotension, or angina.
- Have a past or current history of epilepsy or any other type of seizure disorder, whether controlled or uncontrolled.
- Have undergone major surgery within the past 6 months or hospitalization within the past 3 months.
Tratamiento, grupos y participación
El registro puede describir tratamientos y duración sin incluir un calendario completo. Pide al equipo las visitas, procedimientos, riesgos, costos y alternativas. Mantén tu atención habitual salvo que tu médico te indique un cambio.
- Asignación
- No aplica
- Enmascaramiento
- Sin enmascaramiento
Arm 1
Gait training
Other: Treadmill-integrated virtual reality gait training
Treadmill-integrated virtual reality gait training OTHER
6-week training program with 2 training sessions each week
Qué evalúan los investigadores
Estas medidas indican qué se estudia. No prueban que un tratamiento funcione.
Medidas principales
Spatiotemporal metrics of gait
Plazo: Initial visit to the end of the program in 12 weeks
step length (m)
Spatiotemporal metrics of gait
Plazo: Initial visit to the end of the program in 12 weeks
stride length (m)
Spatiotemporal metrics of gait
Plazo: Initial visit to the end of the program in 12 weeks
step time (s)
Spatiotemporal metrics of gait
Plazo: Initial visit to the end of the program in 12 weeks
single support time (s)
Spatiotemporal metrics of gait
Plazo: Initial visit to the end of the program in 12 weeks
double support time (s)
Spatiotemporal metrics of gait
Plazo: Initial visit to the end of the program in 12 weeks
gait cycle (s)
Spatiotemporal metrics of gait
Plazo: Initial visit to the end of the program in 12 weeks
cadence (steps/s)
Spatiotemporal metrics of gait
Plazo: Initial visit to the end of the program in 12 weeks
stance time (s)
Spatiotemporal metrics of gait
Plazo: Initial visit to the end of the program in 12 weeks
speed(m/s)
Spatiotemporal metrics of gait
Plazo: Initial visit to the end of the program in 12 weeks
swing time (s)
Medidas secundarias
Fear of falling (FOF)
Plazo: Surveys will be conducted at the initial visit, week 2, 5, 8, and 12.
FOF as determined by Falls Efficacy Scale-International (FES-I); Scale: Not at all concerned = 1, Somewhat concerned = 2, Fairly concerned = 3, Very concerned = 4; Lowest score = 16, Highest score = 64, lower scores indicated less FOF (better), higher scores indicated more FOF (worse), total score divided by 64.
Revisa las tablas completas y sus limitaciones en el registro oficial.
Abrir resultados oficiales ↗Centros de investigación (1)
El estado general puede diferir del estado de un centro. Confirma la disponibilidad antes de trasladarte.
1 centros
Shepherd CenterAtlanta, Georgia, United StatesReclutando
Equipo y fechas
- Patrocinador principal
- Shepherd Center, Atlanta GA
- Inicio del estudio
- 31 jul 2026 Real
- Finalización primaria
- 27 abr 2027 Estimado
- Finalización del estudio
- 27 abr 2027 Estimado
- Primera publicación
- 10 nov 2026 Real
- Última actualización
- 10 nov 2026 Real
Contactos oficiales del estudio
Título oficial del estudio
Investigating the Acute and Long-term Effects of Treadmill-integrated Virtual Reality (VR) Training on Real-World Mobility and Fall-Related Outcomes in People With Multiple Sclerosis
Consulta a Wellness Clinical Research
Tu mensaje va a WCR, incluso si otra organización realiza este estudio. WCR puede orientarte, pero podría no realizar este estudio, tener acceso a su equipo ni poder inscribirte.
Fuente: API v2 de ClinicalTrials.gov. Patrocinadores e investigadores envían la información. La NLM no aprueba la seguridad ni la ciencia de todos los estudios registrados. Aviso del registro.
Consultado: 12 nov 2026 · Última actualización del registro: 10 nov 2026
